We recently demonstrated that PBX1 is a pioneer factor in ERα-positive breast cancer, occupying the chromatin prior to ERα binding following its activation with estrogen and regulating the expression of estrogen dependent genes associated with aggressive progression [16]. Here, ESR1 is linked to breast cancer.